Aster DM Healthcare Q4 net profit up 7.1 percent to Rs 219.84 crore Medical Dialogues Bureau31 May 2019 9:30 AM IST"We are very happy to report strong growth at both the top line and EBITDA (Earnings before interest, tax, depreciation and amortisation) level. All...
Theranica wins USFDA nod for smartphone controlled migraine relief wearable device Farhat Nasim31 May 2019 9:25 AM ISTNerivio Migra, a first-in-category product, is placed on the upper arm (not the head or neck) and uses smartphone-controlled electronic pulses to...
Natco Pharma settles patent litigation over generic version of anti-cancer drug Kyprolis Medical Dialogues Bureau30 May 2019 5:12 PM ISTKyprolis is the trade name for the generic drug Carfilzomib. The anti-cancer drug is a targeted therapy and is classified as a Proteasome Inhibitor....
Sun Pharma Whole Time Director Sudhir Valia steps down from executive role Farhat Nasim30 May 2019 10:00 AM ISTEarlier in January 2019, Sun Pharma had said that it had not given any loans nor guarantees to Suraksha Realty, a company in which Sudhir Valia is one...
Addressable medicine market for e-pharmacies in India likely to reach $18.1 billion by 2023: Report Medical Dialogues Bureau30 May 2019 9:45 AM ISTThis expected rise in the acute target market by e-pharmacies, can be attributed to an improvement in last-mile logistics through collaboration with...
Cadila Healthcare posts Q4 net profit of Rs 460 crore Medical Dialogues Bureau30 May 2019 9:15 AM ISTThe consolidated financial statements for the quarter and the year ended March 31, 2019, including the operations of Heinz India Pvt Ltd (HIPL) for...
Misleading information on vaccines should be taken down from social media: Vaccine Chief Medical Dialogues Bureau30 May 2019 9:00 AM ISTAmong the measures being taken to inoculate populations against the spread of misinformation about vaccine safety was putting pressure on social media...
Sun Pharma Q4 profit falls by half to Rs 636 crore due to change in distribution strategy Garima29 May 2019 9:45 AM ISTSun Pharma said the net profit for the fourth quarter of FY2018-19 is not comparable with the year-ago period due to the one-time impact of...
Medikabazaar to raise Rs 200 crore in Series B funding Garima29 May 2019 9:30 AM ISTThis is being done as part of the Medikabazaar's growth and expansion plans to clock in $100 million in revenues in the financial year 2019-20, he...
Mallinckrodt Amitiza to stay with branded business after spin-off Medical Dialogues Bureau29 May 2019 9:15 AM ISTThe company said that it believed the new generics company, which will be called Mallinckrodt Inc, would emerge with less debt than previously...
WHO agrees watered down resolution for clearer drug prices Medical Dialogues Bureau29 May 2019 9:00 AM ISTIt was hailed as a landmark by WHO chief Tedros Adhanom Ghebreyesus and "enthusiastically welcomed" by the United States, which had advocated making...
Manufacturers illegally marketing unauthorized diabetes management devices; USFDA issues warning Medical Dialogues Bureau28 May 2019 10:03 AM ISTAs per the agency note, the USFDA is aware of manufacturers illegally marketing unauthorized devices for diabetes management, which have not been...
